Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Oct. 29, 2016	Jul. 30, 2016	Apr. 30, 2016	Oct. 31, 2015	Aug. 01, 2015	May 02, 2015	Oct. 29, 2016	Oct. 31, 2015
Net Cash Provided by Operating Activities							$ 316	$ 262
Investing Activities:
Capital Expenditures							(825)	(603)
Proceeds from Sale of Other Assets, Investing Activities							0	196
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital							108	0
Proceeds from Sale of Equity Method Investments							0	85
Proceeds from Sale and Maturity of Marketable Securities							10	50
Investment In Equity Affiliates							0
Payments to Acquire Businesses, Net of Cash Acquired							(33)	0
Payments to Acquire Marketable Securities							0	(60)
Other Investing Activities							19	0
Net Cash Provided by (Used for) Investing Activities							(721)	(332)
Financing Activities:
Proceeds from Debt, Net of Issuance Costs							692	988
Repayments of Long-term Debt							(742)	0
Proceeds from Long-term Lines of Credit							20	5
Repayments of Lines of Credit							(4)	0
Repurchases of Common Stock							(410)	(363)
Dividends Paid	$ (173)	$ (173)	$ (750)	$ (146)	$ (146)	$ (734)	(1,096)	(1,026)
Excess Tax Benefits from Share-based Compensation							39	65
Net Financing Activities and Advances to/from Consolidated Affiliates							0	0
Proceeds from Exercise of Stock Options							17	31
Proceeds from (Payments for) Other Financing Activities							(2)	(2)
Net Cash Provided by (Used for) Financing Activities							(1,486)	(302)
Effects of Exchange Rate Changes on Cash and Cash Equivalents							(3)	2
Net Increase (Decrease) in Cash and Cash Equivalents							(1,894)	(370)
Cash and Cash Equivalents, Beginning of Period			2,548			1,681	2,548	1,681
Cash and Cash Equivalents, End of Period	654			1,311			654	1,311
L Brands, Inc.
Net Cash Provided by Operating Activities							(342)	(254)
Investing Activities:
Capital Expenditures							0	0
Proceeds from Sale of Other Assets, Investing Activities								0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital							0
Proceeds from Sale of Equity Method Investments								0
Proceeds from Sale and Maturity of Marketable Securities							0	0
Investment In Equity Affiliates							0
Payments to Acquire Businesses, Net of Cash Acquired							0
Payments to Acquire Marketable Securities								0
Other Investing Activities							0
Net Cash Provided by (Used for) Investing Activities							0	0
Financing Activities:
Proceeds from Debt, Net of Issuance Costs							692	988
Repayments of Long-term Debt							(742)
Proceeds from Long-term Lines of Credit							0	0
Repayments of Lines of Credit							0
Repurchases of Common Stock							(410)	(363)
Dividends Paid							(1,096)	(1,026)
Excess Tax Benefits from Share-based Compensation							0	0
Net Financing Activities and Advances to/from Consolidated Affiliates							1,881	624
Proceeds from Exercise of Stock Options							17	31
Proceeds from (Payments for) Other Financing Activities							0	0
Net Cash Provided by (Used for) Financing Activities							342	254
Effects of Exchange Rate Changes on Cash and Cash Equivalents							0	0
Net Increase (Decrease) in Cash and Cash Equivalents							0	0
Cash and Cash Equivalents, Beginning of Period			0			0	0	0
Cash and Cash Equivalents, End of Period	0			0			0	0
Guarantor Subsidiaries
Net Cash Provided by Operating Activities							402	377
Investing Activities:
Capital Expenditures							(648)	(440)
Proceeds from Sale of Other Assets, Investing Activities								0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital							0
Proceeds from Sale of Equity Method Investments								1
Proceeds from Sale and Maturity of Marketable Securities							0	50
Investment In Equity Affiliates							0
Payments to Acquire Businesses, Net of Cash Acquired							0
Payments to Acquire Marketable Securities								(50)
Other Investing Activities							1
Net Cash Provided by (Used for) Investing Activities							(647)	(439)
Financing Activities:
Proceeds from Debt, Net of Issuance Costs							0	0
Repayments of Long-term Debt							0
Proceeds from Long-term Lines of Credit							0	0
Repayments of Lines of Credit							0
Repurchases of Common Stock							0	0
Dividends Paid							0	0
Excess Tax Benefits from Share-based Compensation							35	57
Net Financing Activities and Advances to/from Consolidated Affiliates							(1,608)	(370)
Proceeds from Exercise of Stock Options							0	0
Proceeds from (Payments for) Other Financing Activities							(2)	(2)
Net Cash Provided by (Used for) Financing Activities							(1,575)	(315)
Effects of Exchange Rate Changes on Cash and Cash Equivalents							0	0
Net Increase (Decrease) in Cash and Cash Equivalents							(1,820)	(377)
Cash and Cash Equivalents, Beginning of Period			2,190			1,462	2,190	1,462
Cash and Cash Equivalents, End of Period	370			1,085			370	1,085
Non- guarantor Subsidiaries
Net Cash Provided by Operating Activities							256	139
Investing Activities:
Capital Expenditures							(177)	(163)
Proceeds from Sale of Other Assets, Investing Activities								196
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital							108
Proceeds from Sale of Equity Method Investments								84
Proceeds from Sale and Maturity of Marketable Securities							10	0
Investment In Equity Affiliates							(27)
Payments to Acquire Businesses, Net of Cash Acquired							(33)
Payments to Acquire Marketable Securities								(10)
Other Investing Activities							18
Net Cash Provided by (Used for) Investing Activities							(101)	107
Financing Activities:
Proceeds from Debt, Net of Issuance Costs							0	0
Repayments of Long-term Debt							0
Proceeds from Long-term Lines of Credit							20	5
Repayments of Lines of Credit							(4)
Repurchases of Common Stock							0	0
Dividends Paid							0	0
Excess Tax Benefits from Share-based Compensation							4	8
Net Financing Activities and Advances to/from Consolidated Affiliates							(246)	(254)
Proceeds from Exercise of Stock Options							0	0
Proceeds from (Payments for) Other Financing Activities							0	0
Net Cash Provided by (Used for) Financing Activities							(226)	(241)
Effects of Exchange Rate Changes on Cash and Cash Equivalents							(3)	2
Net Increase (Decrease) in Cash and Cash Equivalents							(74)	7
Cash and Cash Equivalents, Beginning of Period			358			219	358	219
Cash and Cash Equivalents, End of Period	284			226			284	226
Consolidation, Eliminations [Member]
Investing Activities:
Proceeds from Sale and Maturity of Marketable Securities								0
Consolidation, Eliminations [Member]
Net Cash Provided by Operating Activities							0	0
Investing Activities:
Capital Expenditures							0	0
Proceeds from Sale of Other Assets, Investing Activities								0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital							0
Proceeds from Sale of Equity Method Investments								0
Proceeds from Sale and Maturity of Marketable Securities							0
Investment In Equity Affiliates							27
Payments to Acquire Businesses, Net of Cash Acquired							0
Payments to Acquire Marketable Securities								0
Other Investing Activities							0
Net Cash Provided by (Used for) Investing Activities							27	0
Financing Activities:
Proceeds from Debt, Net of Issuance Costs							0	0
Repayments of Long-term Debt							0
Proceeds from Long-term Lines of Credit							0	0
Repayments of Lines of Credit							0
Repurchases of Common Stock							0	0
Dividends Paid							0	0
Excess Tax Benefits from Share-based Compensation							0	0
Net Financing Activities and Advances to/from Consolidated Affiliates							(27)	0
Proceeds from Exercise of Stock Options							0	0
Proceeds from (Payments for) Other Financing Activities							0	0
Net Cash Provided by (Used for) Financing Activities							(27)	0
Effects of Exchange Rate Changes on Cash and Cash Equivalents							0	0
Net Increase (Decrease) in Cash and Cash Equivalents							0	0
Cash and Cash Equivalents, Beginning of Period			$ 0			$ 0	0	0
Cash and Cash Equivalents, End of Period	$ 0			$ 0			$ 0	$ 0